Recommended Resources
MaRS PICK: Molecular Diagnostics - New tools for evidence-based medicine - MaRS Market Insight
The medical diagnostic (Dx) sector is playing a central role in the shifting health-care and drug discovery landscape. Energized by the demand for changes in the health-care environment and driven by a wave of molecular advances, the Dx sector is responding with innovative new tools and technologies. In this report, we highlight some of the developments fueling this resurgence, focusing not only on key areas of accomplishment and promise, but also on the challenges facing the sector. We place an emphasis on the molecular diagnostics market (MDx), which has the greatest potential to enable the practice of personalized medicine.Ontario is at the forefront of the diagnostics space, with a cluster of vibrant molecular diagnostics and imaging companies, underpinned by an exceptional and collaborative research base possessing strengths in biomarker discovery, optics, materials science and cancer research.
Click to download
BROWSE TOPICS
- Science & Innovation
Articles about emerging technology, organized by scientific discipline - Social Innovation
Best practices for non-profits and companies with a double bottom line - Commercialization & Entrepreneurship
Find information about growing a business, governance and IP - Funding & Financing
Lists of research grants, government funding and VC information - Global Market Reports
Reports on the state of various industries in Canada and abroad
- Scientific Service Providers
Find discounted rates on scientific services and equipment
MaRS BLOG
- Today’s Pick: 2009 INDEX:Award Winners
- Tech for change: A round-up of game-changers
- Cal Stiller: Canadian Hall of Famer
